Chan Zuckerberg’s new center in New York; Endeavor buys rights to ADC; Basilea acquires antifungal
Chan Zuckerberg to launch new research initiative in New York: Meta CEO and co-founder Mark Zuckerberg and Priscilla Chan, his wife and a pediatrician, plan to launch a fourth research center, this time in New York City. The center will focus on new ways to study and engineer immune cells, with plans to invest $250 million over ten years, they announced Wednesday at a STAT event. New York State and New York City are also each contributing $10 million. The New York program will be a collaboration between Columbia University, Rockefeller University and Yale University. Columbia biologist Andrea Califano will direct the center. The Chan Zuckerberg Initiative’s other biohubs are in San Francisco, Chicago and Redwood City, CA. — Lei Lei Wu
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.